Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q2- Text added to 2018 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
addiction, Albert, alectinib, Alzheimer, antigen, atrial, autonomy, Bain, BionTech, Bourla, Breakthrough, Cerevel, ceritinib, Chairman, chimeric, cloud, consummated, crizotinib, Cynamid, deletion, Democratic, dissolving, divestiture, epilepsy, exon, fibrillation, floating, flu, gBRCAm, House, Ian, influenza, installment, involuntary, lira, managerial, midterm, Mississippi, monetize, parent, Parkinson, pivotal, preclinical, preferred, PsA, Quillivant, rituximab, schizophrenia, simpler, slight, soberano, succeed, suspected, tavaborole, thereof, true, Turkish, unchanged
Removed:
AML, BeneFIX, cohort, communicating, contractually, cotransporter, curatively, CV, diabetic, educating, elimination, endocrine, exist, focusing, glucose, good, inspection, McPherson, Merkel, mild, moderate, neuralgia, neuropathic, neuropathy, obligated, ointment, penetration, ReFacto, Senate, topical, twelve, unresectable
Valuein 2018 Q2 filing- Value in 2018 Q3 filing
Original filings
Filing view